RIGL
RIGEL PHARM (RIGL)
NASDAQ
$48.99+$0.11 (+0.23%)
Price as of Oct 22, 2026 7:55 PM EDT
  • $913.1M
    Market Cap
  • 59.27%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
OPPENHEIMERFUNDS, INC.
26.77%
5.0M
0 (0.00%)
Mar 31, 2019
ROCK SPRINGS CAPITAL MANAGEMENT LP
26.35%
4.9M
+61,287 (+1.25%)
Mar 31, 2022
LORD, ABBETT & CO. LLC
23.61%
4.4M
+77,225 (+1.75%)
Mar 31, 2022
BLACKROCK FUND ADVISORS
23.46%
4.4M
+544,631 (+12.43%)
Dec 31, 2016
GREAT POINT PARTNERS LLC
21.41%
4.0M
-1.0M (-25.00%)
Mar 31, 2022
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
18.16%
3.4M
+110,008 (+3.24%)
Dec 31, 2016
LAURION CAPITAL MANAGEMENT LP
17.58%
3.3M
+300,000 (+9.13%)
Mar 31, 2022

Current Ownership Distribution

  • Institutions1.3B (61.67%)
  • Mutual Funds823.5M (37.71%)
  • Insiders13.6M (0.62%)
  • Other0 (0.00%)

Insider Transactions

  • 0.62% (13.6M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 2
    Number of InsiderSelling (last 12 months)
  • $584,006.92
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Schorno Dean L
EVP & Chief Financial Officer
Exempt
Sep 02, 2026
$0.00
694
$0.00
12,824
Schorno Dean L
EVP & Chief Financial Officer
Exempt
Sep 02, 2026
$0.00
620
$0.00
9,012
Schorno Dean L
EVP & Chief Financial Officer
Exempt
Sep 02, 2026
$0.00
2,000
$0.00
7,999
Schorno Dean L
EVP & Chief Financial Officer
Exempt
Sep 02, 2026
$0.00
1,286
$0.00
15,867
Schorno Dean L
EVP & Chief Financial Officer
Exempt
Sep 02, 2026
$8,813.80
694
$12.70
79,056
Schorno Dean L
EVP & Chief Financial Officer
Exempt
Sep 02, 2026
$11,594.00
620
$18.70
79,676
Schorno Dean L
EVP & Chief Financial Officer
Exempt
Sep 02, 2026
$48,400.00
2,000
$24.20
81,676
Schorno Dean L
EVP & Chief Financial Officer
Exempt
Sep 02, 2026
$31,121.20
1,286
$24.20
82,962
Schorno Dean L
EVP & Chief Financial Officer
In Kind
Sep 01, 2026
$44,080.00
928
$47.50
78,362
Ali-Jackson Kamil
Sell
Jun 22, 2026
$87,500.00
2,500
$35.00
10,125
Santos David A
EVP, Chief Commercial Officer
Award
Jun 17, 2026
$0.00
7,394
$0.00
7,394
RODRIGUEZ RAUL R
CEO, President
Award
Jun 17, 2026
$0.00
31,700
$0.00
31,700
Rojkjaer Lisa
EVP, Chief Medical Officer
Award
Jun 17, 2026
$0.00
9,375
$0.00
9,375
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Award
Jun 17, 2026
$0.00
7,394
$0.00
7,394
Rojkjaer Lisa
EVP, Chief Medical Officer
Award
Jun 17, 2026
$0.00
7,394
$0.00
7,394
Schorno Dean L
EVP & Chief Financial Officer
Award
Jun 17, 2026
$0.00
7,394
$0.00
7,394
MOOS WALTER H
Exempt
Feb 20, 2026
$0.00
4,000
$0.00
0
MOOS WALTER H
Exempt
Feb 20, 2026
$96,000.00
4,000
$24.00
16,722
MOOS WALTER H
Sell
Feb 20, 2026
$145,440.00
4,000
$36.36
12,722
Rojkjaer Lisa
EVP, Chief Medical Officer
In Kind
Feb 10, 2026
$130,101.96
3,758
$34.62
15,959
Santos David A
EVP, Chief Commercial Officer
In Kind
Feb 10, 2026
$122,762.52
3,546
$34.62
43,440
Furey Raymond J.
EVP, GC, CCO & Corp Sec
In Kind
Feb 10, 2026
$122,762.52
3,546
$34.62
32,316
Schorno Dean L
EVP & Chief Financial Officer
In Kind
Feb 10, 2026
$122,762.52
3,546
$34.62
55,701
RODRIGUEZ RAUL R
CEO, President
In Kind
Feb 10, 2026
$263,354.34
7,607
$34.62
228,102
Schorno Dean L
EVP & Chief Financial Officer
In Kind
Feb 02, 2026
$197,622.88
5,488
$36.01
59,247
Santos David A
EVP, Chief Commercial Officer
In Kind
Feb 02, 2026
$205,905.18
5,718
$36.01
46,986
RODRIGUEZ RAUL R
CEO, President
In Kind
Feb 02, 2026
$508,101.10
14,110
$36.01
235,709
MILLER MICHAEL PATRICK
Award
Feb 01, 2026
$0.00
12,000
$0.00
12,000
RODRIGUEZ RAUL R
CEO, President
Exempt
Jan 26, 2026
$0.00
40,000
$0.00
0
RODRIGUEZ RAUL R
CEO, President
Exempt
Jan 26, 2026
$0.00
40,000
$0.00
0